Legality of Cannabis by U.S. Jurisdiction

To add an entry, see Wikipedia:WikiProject_Medicine/Tools#Requests. This article is intended to be "a complete list of titles from one specific source, not a general list of potential cancer related articles" [1]

This list contains subjects important to cancer research.

Prior to pruning, this list contained 5,004 entries. Before removing blue links from this list, please check them to make sure they actually cover the intended subject.

Public domain sources: Dictionary of Cancer Terms

  1. ABT-751
  2. AD 32 - currently redirects into year 32
  3. AE-941
  4. AG2037
  5. Adjunct agent
  6. Adjunct therapy
  7. Adjunctive therapy
  8. Aerodigestive tract
  9. Aerosolize
  10. Aminocamptothecin
  11. Androgen-independent
  12. Antiapoptotic
  13. Antisense c-fos
  14. Arginine butyrate
  15. Autologous bone marrow
  16. Axillary dissection
  17. Axillary lymph node dissection
  18. B3 antigen
  19. B43-PAP immunotoxin
  20. BAY 12-9566
  21. BAY 43-9006
  22. BAY 56-3722
  23. BAY 59-8862
  24. BB-10901
  25. BBBD
  26. BBIC
  27. BG00001
  28. BIBX 1382
  29. BI 2536
  30. BL22 immunotoxin
  31. BMS-184476
  32. BMS-188797
  33. BMS-214662
  34. BMS-275291
  35. BMS-599626
  36. Benzoylphenylurea
  37. Beriplast P
  38. Beta alethine
  39. Biafine cream
  40. Bilateral cancer
  41. Bilateral prophylactic mastectomy
  42. Biochemical reactions
  43. Bizelesin
  44. Blood-brain barrier disruption
  45. Bone marrow ablation
  46. Bone marrow metastases
  47. Boronophenylalanine-fructose complex
  48. Bowel function
  49. Bowman-Birk inhibitor concentrate
  50. Breast density
  51. CC-8490
  52. CC49-streptavidin
  53. CEA assay
  54. CEP-2563 dihydrochloride
  55. CGP 48664
  56. CHS 828
  57. CI-958
  58. CI-980
  59. CI-994
  60. CNS metastasis
  61. CNS prophylaxis
  62. CNS sanctuary therapy
  63. CNS tumor
  64. CP-547,632
  65. CP-609,754
  66. CP-724,714
  67. CP4071
  68. CT-2584
  69. Caloric intake
  70. Camptothecin analog
  71. Carbon-11 acetate
  72. Carboxypeptidase-G2
  73. Carcinostatic
  74. Carzelesin
  75. Cellular adoptive immunotherapy
  76. Central nervous system metastasis
  77. Central nervous system primitive neuroectodermal tumor
  78. Central nervous system prophylaxis
  79. Central nervous system sanctuary therapy
  80. Child-life worker
  81. Chloroquinoxaline sulfonamide
  82. Chronic lymphoblastic leukemia
  83. Chronic phase
  84. Clinical breast exam
  85. Clinical resistance
  86. Coactivated T cell
  87. Comfort care
  88. Complete metastasectomy
  89. Concurrent therapy
  90. Consensus Development Program
  91. Consolidation therapy
  92. Constitutional acupuncture
  93. Contiguous lymphoma
  94. Continent reservoir
  95. Continuous infusion
  96. Contrast material
  97. Control animal
  98. Controlled low-voltage electrical stimulation
  99. CpG 7909
  100. Crisnatol mesylate
  101. Cutaneous breast cancer
  102. Cytochlor
  103. Cytotoxic chemotherapy
  104. D-20761
  105. DTGM fusion protein
  106. DX-52-1
  107. De qi sensation
  108. Dendritic cell vaccine
  109. DepoFoam-encapsulated cytarabine
  110. Dextroamphetamine-amphetamine
  111. Dextromethorphan acetic acid
  112. Di-dgA-RFB4
  113. Diagnostic trial
  114. Diaziquone
  115. Dietary protocol
  116. Dihematoporphyrin ether
  117. Dimesna
  118. Dimethylxanthenone acetic acid
  119. Disease-specific survival
  120. Disease progression
  121. Distant cancer
  122. Dolastatin 10
  123. Dose-dependent
  124. Dose-limiting
  125. Dose-rate
  126. Doxorubicin hydrochloride pegylated liposomes
  127. E7070
  128. EKB-569
  129. EMD 121974
  130. EP-2101
  131. EPO906
  132. ERA-923
  133. ERUS
  134. Early-stage breast cancer
  135. Ectocervical
  136. Edatrexate
  137. Edotecarin
  138. Electroporation therapy
  139. Eligibility criteria
  140. Emitefur
  141. Endocrine cancer
  142. Endocrine therapy
  143. Endometrial disorder
  144. Endorectal ultrasound
  145. Eniluracil
  146. Epithelial carcinoma
  147. Epithelial ovarian cancer
  148. Erb-38 immunotoxin
  149. Erythroleukoplakia
  150. Ethynyluracil
  151. Evaluable disease
  152. Evaluable patients
  153. Ewing's family of tumors
  154. Exatecan mesylate
  155. Extensive-stage small cell lung cancer
  156. External-beam radiation
  157. External radiation
  158. Extracranial
  159. Extracranial germ cell tumor
  160. Extragonadal germ cell tumor
  161. Extrahepatic
  162. Extrapleural pneumonectomy
  163. Fast-neutron beam radiation
  164. Fazarabine
  165. Fenretinide LXS
  166. Fenretinide Lym-X-Sorb
  167. Ferumoxtran-10
  168. Filgrastim-SD/01
  169. Five element acupuncture
  170. Fluorine F 18 EF5
  171. Fluoropyrimidine
  172. Fluorothymidine F 18
  173. Follicular mixed cell lymphoma
  174. Forodesine hydrochloride
  175. GEM 231
  176. GI14721
  177. GM2-KLH vaccine
  178. GPX-100
  179. GTI-2040
  180. GW786034
  181. Gadolinium texaphyrin
  182. Gail model
  183. Gamma irradiation
  184. Gamma scanning
  185. Garden valerian
  186. Gastric atrophy
  187. Gastrointestinal carcinoid tumor
  188. Geldanamycin analog
  189. Gene-modified
  190. Germ-free
  191. Gimatecan
  192. Glycinamide ribonucleotide formyltransferase inhibitor
  193. Gp209-2M
  194. Gp96 HSP-peptide complex
  195. Gp96 heat shock protein-peptide complex vaccine
  196. Grade 1 follicular lymphoma
  197. Grade 2 follicular lymphoma
  198. Grade 3 follicular lymphoma
  199. Gray elm
  200. HCD20
  201. HCRF
  202. HIV antibody
  203. Halofuginone hydrobromide
  204. Hawthorn fruit
  205. Hematogenous
  206. Hematologic cancer
  207. Hematopoietic tissue
  208. Hematoporphyrin derivative
  209. Hemilaryngectomy
  210. Hepatic arterial occlusion
  211. Herba scutellaria barbatae
  212. Heterogenic
  213. Hexyl 5-aminolevulinate
  214. High-dose-rate remote brachytherapy
  215. High-dose-rate remote radiation therapy
  216. High-dose chemotherapy
  217. High-dose radiation
  218. High-energy photon therapy
  219. High-grade squamous intraepithelial lesion
  220. High-risk cancer
  221. High grade
  222. Histiocytic lymphoma
  223. Histologic examination
  224. Historical control subject
  225. Holmium Ho 166 DOTMP
  226. Hormone receptor test
  227. Hormone responsive
  228. Hot nodule
  229. Hu14.18-interleukin-2 fusion protein
  230. Hu3S193
  231. HuHMFG1
  232. Huang Lian
  233. Hurthle cell neoplasm
  234. Hydroxymethylglutaryl-coenzyme A reductase inhibitor
  235. IBMFS
  236. ICI D1694
  237. IDEC-Y2B8
  238. IH636 grape seed extract
  239. ILX-295501
  240. ILX23-7553
  241. IM-862
  242. INS316
  243. ISIS 2503
  244. ISIS 3521
  245. ISIS 5132
  246. Imaging procedure
  247. Immune system tolerance
  248. Immunoassay fecal occult blood test
  249. Immunochemical fecal occult blood test
  250. Immunologic fecal occult blood test
  251. Implantable pump
  252. In situ cancer
  253. Incomplete Freund's adjuvant
  254. Indian valerian
  255. Indium In 111 pentetreotide
  256. Indolent lymphoma
  257. Induction therapy
  258. Infiltrating cancer
  259. Infrared coagulation
  260. Inherited bone marrow failure syndrome
  261. Intensification therapy
  262. Intensity-modulated radiation therapy
  263. Interfering thought
  264. Interleukin-13 PE38QQR immunotoxin
  265. Interleukin-4 PE38KDEL cytotoxin
  266. Interleukin-4 PE38KDEL immunotoxin
  267. Intermediate-grade lymphoma
  268. Interstitial radiation
  269. Intervention group
  270. Intoplicine
  271. Intoxicating pepper
  272. Intracarotid infusion
  273. Intracavitary
  274. Intracavitary radiation
  275. Intracolonic
  276. Intracutaneous
  277. Intraepithelial
  278. Intrahepatic
  279. Intrahepatic infusion
  280. Intralesional
  281. Intraluminal intubation and dilation
  282. Intraocular
  283. Intrapelvic
  284. Intraperitoneal chemotherapy
  285. Intraperitoneal infusion
  286. Intraperitoneal radiation therapy
  287. Intraspinal
  288. Intrathecal chemotherapy
  289. Intratumoral
  290. Intravaginal
  291. Intraventricular infusion
  292. Invasive cervical cancer
  293. Investigational
  294. Iodine I 131 monoclonal antibody BC8
  295. Iododoxorubicin
  296. Irreversible toxicity
  297. Iseganan hydrochloride
  298. Isointense
  299. J-107088
  300. Jiang huang
  301. KOS-862
  302. KRN5500
  303. KRN7000
  304. KW2189
  305. Karenitecin
  306. Korean acupuncture
  307. L-377,202
  308. L-778,123
  309. L-threo-dihydrosphingosine
  310. LED therapy
  311. LEP-ETU
  312. LMB-1 immunotoxin
  313. LMB-2 immunotoxin
  314. LMB-7 immunotoxin
  315. LMB-9 immunotoxin
  316. LU-103793
  317. LU 79553
  318. LY293111
  319. LY353381 hydrochloride
  320. Labial mucosa
  321. Laboratory study
  322. Laboratory test
  323. Laparoscopic-assisted colectomy
  324. Laparoscopic prostatectomy
  325. Laser acupuncture
  326. Leptomeningeal metastases
  327. Leridistim
  328. Leuvectin
  329. Liarozole
  330. Light-emitting diode therapy
  331. Limited-stage small cell lung cancer
  332. Liposomal SN-38
  333. Liquid-based Pap test
  334. Liver metastases
  335. Liver scan
  336. Lobaplatin
  337. Lobradimil
  338. Local cancer
  339. Local therapy
  340. Localized gallbladder cancer
  341. Localized malignant mesothelioma
  342. Locally advanced cancer
  343. Lometrexol
  344. Losoxantrone
  345. Low-grade lymphoma
  346. Low grade
  347. Lung metastases
  348. Luteinizing hormone-releasing hormone agonist
  349. Lymph node drainage
  350. Lymph node mapping
  351. Lymphatic basin
  352. Lymphatic mapping
  353. Lytic lesion
  354. MDL 101,731
  355. MDX-060
  356. MG98
  357. MLN2704
  358. MLN591DM1
  359. MS 209
  360. Malignant mixed Müllerian tumor
  361. Mantle field
  362. Mature T-cell lymphoma
  363. Maximum inspiratory pressure test
  364. MeV linear accelerator
  365. Mean survival time
  366. Measurable disease
  367. Medical castration
  368. Medical oncologist
  369. Mega-voltage linear accelerator
  370. Meningeal
  371. Meningeal metastases
  372. Mesenteric membrane
  373. Metasynchronous
  374. Methyl-5-aminolevulinate
  375. Metronomic therapy
  376. Microwave acupuncture
  377. Mistletoe lectin
  378. Mitolactol
  379. Mitotic activity
  380. Mivobulin isethionate
  381. Monoclonal protein
  382. Montanide ISA-51
  383. MuJ591
  384. Mucin/peptide
  385. Multicenter study
  386. Multicentric breast cancer
  387. Multidisciplinary opinion
  388. Multidrug resistance inhibition
  389. Multifocal breast cancer
  390. Multimodality treatment
  391. Mycosis fungoides plaque
  392. Myelogenous
  393. Myelosuppressive therapy
  394. N-acetyldinaline
  395. N-benzoyl-staurosporine
  396. N-butyl-N-(4-hydroxybutyl) nitrosamine
  397. NBI-3001
  398. NCI clinical trials cooperative group
  399. NGR-TNF
  400. NR-LU-10 antigen
  401. NSC 655649
  402. Nanoparticle paclitaxel
  403. Nasoscopy
  404. Negative axillary lymph node
  405. Negative test result
  406. Nephrotomogram
  407. Nephroureterectomy
  408. Nerve-sparing radical prostatectomy
  409. Nerve grafting
  410. Neuro-oncologist
  411. Neurobehavioral
  412. Neuroepithelial
  413. Neuroradiologist
  414. Nitrocamptothecin
  415. Node-negative
  416. Node-positive
  417. Nonblinded
  418. Noncontiguous lymphoma
  419. Nonfunctioning tumor
  420. Nonhematologic cancer
  421. Nonlytic
  422. Nonmalignant
  423. Nonmalignant hematologic disorder
  424. Nonmelanomatous
  425. Nonmetastatic
  426. Nonopioid
  427. Nonprescription
  428. Nonrandomized clinical trial
  429. Nonsteroidal aromatase inhibitor
  430. Nuclear medicine scan
  431. Nutrition therapy
  432. Nutritional status
  433. OGX-011
  434. OTI-010
  435. OXi-104
  436. Oat cell cancer
  437. Objective improvement
  438. Objective response
  439. Occult stage non-small cell lung cancer
  440. Oncology pharmacy specialist
  441. Oncolysate
  442. Oncolysis
  443. Open colectomy
  444. Ovarian ablation
  445. Ovarian germ cell tumor
  446. Ovarian suppression
  447. PALA
  448. PEG-MGDF
  449. PEG-asparaginase
  450. PEG-rhMGDF
  451. PF-00299804
  452. PF-3512676
  453. PI-88
  454. PM-81
  455. PN401
  456. PNU-93914
  457. PNU 166148
  458. PSC 833
  459. PTCD
  460. PV701
  461. Pacific valerian
  462. Paclitaxel (Albumin-Stabilized Nanoparticle Formulation)
  463. Paclitaxel liposome
  464. Paclitaxel poliglumex
  465. Paclitaxel polyglutamate
  466. Palmar-plantar erythodysthesia
  467. Palpable disease
  468. Papillary serous carcinoma
  469. Paranasal sinus and nasal cavity cancer
  470. Parotidectomy
  471. Partial hysterectomy
  472. Partial laryngectomy
  473. Partial mastectomy
  474. Partial oophorectomy
  475. Partial response
  476. Passive antibody therapy
  477. Pathology report
  478. Pediatric nurse specialist
  479. Pegylated liposomal doxorubicin
  480. Peldesine
  481. Pelvic lymphadenectomy
  482. Penclomedine
  483. Pentetic acid calcium
  484. Peptide 946
  485. Percutaneous ethanol injection
  486. Percutaneous transhepatic biliary drainage
  487. Percutaneous transhepatic cholangiodrainage
  488. Perfusion magnetic resonance imaging
  489. Perillyl alcohol
  490. Perineal colostomy
  491. Perineal prostatectomy
  492. Perineural
  493. Peripheral primitive neuroectodermal tumor
  494. Peripheral stem cell
  495. Peripheral stem cell support
  496. Peritoneal infusion
  497. Peritoneal perfusion
  498. Phase II detoxification
  499. Phase I detoxification
  500. Phenoxodiol
  501. Phospholipid complex
  502. Photoactivity
  503. Photon-beam radiation
  504. Pineal region tumor
  505. Piritrexim
  506. Placebo therapy
  507. Placental blood transplantation
  508. Plasmacytic
  509. Polifeprosan 20 carmustine implant
  510. Polyethylene glycosylated recombinant human megakaryocyte
  511. Polyglutamate camptothecin
  512. Porfiromycin
  513. Positive test result
  514. Posterior pelvic exenteration
  515. Postremission therapy
  516. Potentiation
  517. Precancerous polyps
  518. Predictive factor
  519. Presacral
  520. Pretracheal space
  521. Prevascular space
  522. Preventive
  523. Primary endpoint
  524. ProMune
  525. Progesterone receptor negative
  526. Progesterone receptor positive
  527. Progesterone receptor test
  528. Prognostic factor
  529. Proliferating
  530. Prophylactic cranial irradiation
  531. Prophylactic oophorectomy
  532. Prophylactic surgery
  533. Prost 30
  534. Prostatocystectomy
  535. Proteomic profile
  536. Proton magnetic resonance spectroscopic imaging
  537. Pulmonary rehabilitation education
  538. Purple clover
  539. Pyrazine diazohydroxide
  540. Pyrazoloacridine
  541. Pyroxamide
  542. R101933
  543. RAV12
  544. RK-0202
  545. RMP-7
  546. RPR 109881A
  547. Radiation fibrosis
  548. Radiation nurse
  549. Radiation physicist
  550. Radiation surgery
  551. Radical cystectomy
  552. Radical local excision
  553. Radical nephrectomy
  554. Radioactive palladium
  555. Radioactive seed
  556. Radiologic exam
  557. Radionuclide scanning
  558. Radiosensitization
  559. Rapid-onset opioid
  560. Ras peptide
  561. Rebeccamycin analog
  562. Rectal reconstruction
  563. Rectitis
  564. Recurrent cancer
  565. Refractory cancer
  566. Regional cancer
  567. Regional chemotherapy
  568. Regional lymph node
  569. Regional lymph node dissection
  570. Rehabilitation specialist
  571. Remission induction therapy
  572. Remote brachytherapy
  573. Replication cycle
  574. Resectable
  575. Resected
  576. Residual disease
  577. Resistant cancer
  578. Retromolar trigone
  579. Retropubic prostatectomy
  580. Retroviral vector
  581. RevM10 gene
  582. Ro 31-7453
  583. Ro 50-3821
  584. S-phase fraction
  585. SB-715992
  586. SC-70935
  587. SCH-58500
  588. SCH 54031
  589. SCH 66336
  590. SGN-00101
  591. SGN-15
  592. SGN-30
  593. SJG-136
  594. SL-11047
  595. SN-38 liposome
  596. SR-29142
  597. SR-45023A
  598. ST1481
  599. SU006668
  600. SU6668
  601. SarCNU
  602. Sarcosinamide nitrosourea
  603. Second-look surgery
  604. Second primary cancer
  605. Sedoxantrone trihydrochloride
  606. Segmental cystectomy
  607. Segmental mastectomy
  608. Seminal vesicle biopsy
  609. Semiparasitic
  610. Seocalcitol
  611. Sequential treatment
  612. Serum tumor marker test
  613. Sestamibi breast imaging
  614. Severe myelosuppression
  615. Sialyl Tn-KLH
  616. Silicon phthalocyanine 4
  617. Simple mastectomy
  618. Simple nephrectomy
  619. Skin stimulation
  620. Skinning vulvectomy
  621. SnET2
  622. Soblidotin
  623. Sodium borocaptate
  624. Somnolence syndrome
  625. Specific immune cell
  626. Sputum cytology
  627. Stable disease
  628. Stage 0 anal cancer
  629. Stage 0 bladder cancer
  630. Stage 0 cervical cancer
  631. Stage 0 chronic lymphocytic leukemia
  632. Stage 0 colorectal cancer
  633. Stage 0 esophageal cancer
  634. Stage 0 extrahepatic bile duct cancer
  635. Stage 0 gallbladder cancer
  636. Stage 0 gastric cancer
  637. Stage 0 hypopharyngeal cancer
  638. Stage 0 laryngeal cancer
  639. Stage 0 melanoma
  640. Stage 0 nasopharyngeal cancer
  641. Stage 0 non-small cell lung cancer
  642. Stage 0 skin cancer
  643. Stage 0 testicular cancer
  644. Stage 0 transitional cell cancer of the renal pelvis and ureter
  645. Stage 1 neuroblastoma
  646. Stage 2 neuroblastoma
  647. Stage 3 neuroblastoma
  648. Stage 4 neuroblastoma
  649. Stage A1 prostate cancer
  650. Stage A2 prostate cancer
  651. Stage B1 prostate cancer
  652. Stage B2 prostate cancer
  653. Stage C prostate cancer
  654. Stage D1 prostate cancer
  655. Stage D2 prostate cancer
  656. Stage IA gallbladder cancer
  657. Stage IA soft tissue sarcoma
  658. Stage IB gallbladder cancer
  659. Stage IB soft tissue sarcoma
  660. Stage IIA breast cancer
  661. Stage IIA gallbladder cancer
  662. Stage IIA soft tissue sarcoma
  663. Stage IIB breast cancer
  664. Stage IIB gallbladder cancer
  665. Stage IIB melanoma
  666. Stage IIB soft tissue sarcoma
  667. Stage IIC soft tissue sarcoma
  668. Stage IIIA adult primary liver cancer
  669. Stage IIIA anal cancer
  670. Stage IIIA breast cancer
  671. Stage IIIB adult primary liver cancer
  672. Stage IIIB anal cancer
  673. Stage IIIB breast cancer
  674. Stage IIIC adult primary liver cancer
  675. Stage IIIC breast cancer
  676. Stage III AIDS-related lymphoma
  677. Stage III Wilms' tumor
  678. Stage III adrenocortical cancer
  679. Stage III adult Hodgkin's lymphoma
  680. Stage III adult non-Hodgkin's lymphoma
  681. Stage III anal cancer
  682. Stage III bladder cancer
  683. Stage III breast cancer
  684. Stage III cancer of the uterus
  685. Stage III cancer of the vulva
  686. Stage III cervical cancer
  687. Stage III childhood liver cancer
  688. Stage III childhood non-Hodgkin's lymphoma
  689. Stage III chronic lymphocytic leukemia
  690. Stage III colorectal cancer
  691. Stage III cutaneous T-cell lymphoma
  692. Stage III endometrial cancer
  693. Stage III esophageal cancer
  694. Stage III extrahepatic bile duct cancer
  695. Stage III gallbladder cancer
  696. Stage III gastric cancer
  697. Stage III hypopharyngeal cancer
  698. Stage III kidney cancer
  699. Stage III laryngeal cancer
  700. Stage III lip and oral cavity cancer
  701. Stage III malignant mesothelioma
  702. Stage III melanoma
  703. Stage III mycosis fungoides and the Sézary syndrome
  704. Stage III nasopharyngeal cancer
  705. Stage III non-small cell lung cancer
  706. Stage III oropharynx cancer
  707. Stage III ovarian cancer
  708. Stage III pancreatic cancer
  709. Stage III prostate cancer
  710. Stage III renal cell cancer
  711. Stage III skin cancer
  712. Stage III soft tissue sarcoma
  713. Stage III testicular cancer
  714. Stage III transitional cell cancer of the renal pelvis and ureter
  715. Stage II AIDS-related lymphoma
  716. Stage II Wilms' tumor
  717. Stage II adrenocortical cancer
  718. Stage II adult Hodgkin's lymphoma
  719. Stage II adult non-Hodgkin's lymphoma
  720. Stage II adult primary liver cancer
  721. Stage II anal cancer
  722. Stage II bladder cancer
  723. Stage II breast cancer
  724. Stage II cancer of the uterus
  725. Stage II cancer of the vulva
  726. Stage II cervical cancer
  727. Stage II childhood liver cancer
  728. Stage II childhood non-Hodgkin's lymphoma
  729. Stage II chronic lymphocytic leukemia
  730. Stage II colorectal cancer
  731. Stage II cutaneous T-cell lymphoma
  732. Stage II endometrial cancer
  733. Stage II esophageal cancer
  734. Stage II extrahepatic bile duct cancer
  735. Stage II gastric cancer
  736. Stage II hypopharyngeal cancer
  737. Stage II kidney cancer
  738. Stage II laryngeal cancer
  739. Stage II lip and oral cavity cancer
  740. Stage II malignant mesothelioma
  741. Stage II melanoma
  742. Stage II multiple myeloma
  743. Stage II mycosis fungoides and the Sézary syndrome
  744. Stage II nasopharyngeal cancer
  745. Stage II non-small cell lung cancer
  746. Stage II oropharynx cancer
  747. Stage II ovarian cancer
  748. Stage II pancreatic cancer
  749. Stage II prostate cancer
  750. Stage II renal cell cancer
  751. Stage II skin cancer
  752. Stage II testicular cancer
  753. Stage II transitional cell cancer of the renal pelvis and ureter
  754. Stage IVA hypopharyngeal cancer
  755. Stage IVA laryngeal cancer
  756. Stage IVA pancreatic cancer
  757. Stage IVB hypopharyngeal cancer
  758. Stage IVB laryngeal cancer
  759. Stage IVB pancreatic cancer
  760. Stage IVC hypopharyngeal cancer
  761. Stage IVC laryngeal cancer
  762. Stage IV AIDS-related lymphoma
  763. Stage IV Wilms' tumor
  764. Stage IV adrenocortical cancer
  765. Stage IV adult Hodgkin's lymphoma
  766. Stage IV adult non-Hodgkin's lymphoma
  767. Stage IV adult primary liver cancer
  768. Stage IV anal cancer
  769. Stage IV bladder cancer
  770. Stage IV cancer of the uterus
  771. Stage IV cancer of the vulva
  772. Stage IV cervical cancer
  773. Stage IV childhood liver cancer
  774. Stage IV childhood non-Hodgkin's lymphoma
  775. Stage IV chronic lymphocytic leukemia
  776. Stage IV colorectal cancer
  777. Stage IV cutaneous T-cell lymphoma
  778. Stage IV endometrial cancer
  779. Stage IV esophageal cancer
  780. Stage IV extrahepatic bile duct cancer
  781. Stage IV gallbladder cancer
  782. Stage IV gastric cancer
  783. Stage IV hypopharynx cancer
  784. Stage IV kidney cancer
  785. Stage IV laryngeal cancer
  786. Stage IV lip and oral cavity cancer
  787. Stage IV malignant mesothelioma
  788. Stage IV melanoma
  789. Stage IV mycosis fungoides and the Sézary syndrome
  790. Stage IV nasopharyngeal cancer
  791. Stage IV non-small cell lung cancer
  792. Stage IV oropharynx cancer
  793. Stage IV ovarian cancer
  794. Stage IV pancreatic cancer
  795. Stage IV prostate cancer
  796. Stage IV renal cell cancer
  797. Stage IV skin cancer
  798. Stage IV soft tissue sarcoma
  799. Stage IV transitional cell cancer of the renal pelvis and ureter
  800. Stage I AIDS-related lymphoma
  801. Stage I Wilms' tumor
  802. Stage I adrenocortical cancer
  803. Stage I adult Hodgkin's lymphoma
  804. Stage I adult non-Hodgkin's lymphoma
  805. Stage I adult primary liver cancer
  806. Stage I anal cancer
  807. Stage I bladder cancer
  808. Stage I breast cancer
  809. Stage I cancer of the uterus
  810. Stage I cancer of the vulva
  811. Stage I cervical cancer
  812. Stage I childhood liver cancer
  813. Stage I childhood non-Hodgkin's lymphoma
  814. Stage I chronic lymphocytic leukemia
  815. Stage I colorectal cancer
  816. Stage I cutaneous T-cell lymphoma
  817. Stage I endometrial cancer
  818. Stage I esophageal cancer
  819. Stage I extrahepatic bile duct cancer
  820. Stage I gastric cancer
  821. Stage I hypopharyngeal cancer
  822. Stage I kidney cancer
  823. Stage I laryngeal cancer
  824. Stage I lip and oral cavity cancer
  825. Stage I malignant mesothelioma
  826. Stage I melanoma
  827. Stage I multiple myeloma
  828. Stage I mycosis fungoides and the Sézary syndrome
  829. Stage I nasopharyngeal cancer
  830. Stage I non-small cell lung cancer
  831. Stage I oropharynx cancer
  832. Stage I ovarian cancer
  833. Stage I pancreatic cancer
  834. Stage I prostate cancer
  835. Stage I renal cell cancer
  836. Stage I skin cancer
  837. Stage I testicular cancer
  838. Stage I transitional cell cancer of the renal pelvis and ureter
  839. Stage V Wilms' tumor
  840. Standard therapy
  841. Stemgen
  842. Stereotactic body radiation therapy
  843. Stereotactic external-beam radiation
  844. Stereotaxic radiosurgery
  845. Steroid cream
  846. Steroid drug
  847. Steroid therapy
  848. Stromagen
  849. Study agent
  850. Subependymal
  851. Subjective improvement
  852. Subset analysis
  853. Subtenon
  854. Sun's Soup
  855. Superfractionated radiation therapy
  856. Supplemental nutrition
  857. Supplementation
  858. Supportive care
  859. Supraglottic laryngectomy
  860. Surface electrode
  861. Sweet elm
  862. Symptom management
  863. Synthetic protegrin analog
  864. Synthetic retinoid
  865. Systemic chemotherapy
  866. Systemic radiation
  867. T-cell acute lymphocytic leukemia
  868. T-cell depletion
  869. T138067
  870. T4N5 liposomal lotion
  871. T900607
  872. TAC-101
  873. TG4010
  874. TLK286
  875. TNP-470
  876. TP-38 immunotoxin
  877. TSEB therapy
  878. TTI-237
  879. TZT-1027
  880. Talaporfin sodium
  881. Talotrexin
  882. Technetium tc 99m dextran
  883. Telcyta
  884. Tetrahydrouridine
  885. Third-line therapy
  886. Thoracalgia
  887. Thoracodynia
  888. Thymitaq
  889. Tin Sn 117m DTPA
  890. Tin ethyl etiopurpurin
  891. Tocladesine
  892. Topical chemotherapy
  893. Total androgen blockade
  894. Total estrogen blockade
  895. Total laryngectomy
  896. Total nodal irradiation
  897. Total skin electron beam radiation therapy
  898. Traditional acupuncture
  899. Transabdominal ultrasound
  900. Transferrin-CRM107
  901. Transvaginal sonography
  902. Traumeel S
  903. Treatment field
  904. Triacetyluridine
  905. Trigger point acupuncture
  906. Tumor-derived
  907. Tumor burden
  908. Tumor load
  909. Tumor model
  910. Tumor vasculature–targeted tumor necrosis factor alpha
  911. Tumor volume
  912. Tyrosinase peptide
  913. UCN-01
  914. Ultraviolet radiation therapy
  915. Uncontrolled study
  916. Unconventional cancer treatments
  917. Unilateral salpingo-oophorectomy
  918. Unresectable
  919. Unresectable gallbladder cancer
  920. Unresected
  921. Unsealed internal radiation therapy
  922. Ureteronephrectomy
  923. Urologic oncologist
  924. VEGF-AS
  925. VEGF Trap
  926. VNP20009
  927. VNP40101M
  928. VX 853
  929. Vaccinia CEA vaccine
  930. Valerianae radix
  931. Vascular endothelial growth factor-antisense oligonucleotide
  932. Velafermin
  933. Video-assisted resection
  934. Video-assisted surgery
  935. Virulizin
  936. Virus-neutralizing antibody
  937. Well-differentiated lymphocytic lymphoma
  938. Whole cell vaccine
  939. Wild clover
  940. Wobe-Mugos E
  941. Xentuzumab
  942. XK469R
  943. XR9576
  944. XRP9881
  945. Xyotax
  946. YM598
  947. Yangona
  948. ZD0473